Literature DB >> 33552090

B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps.

Zhe-Zheng Wang1, Jia Song1, Hai Wang1, Jing-Xian Li1, Qiao Xiao1, Ze Yu1, Jin-Xin Liu1, Zheng Liu1.   

Abstract

Ectopic lymphoid tissues (eLTs) characterized by B cell aggregation contribute to the local immunoglobulin production in nasal polyps (NPs). B cell-activating factor (BAFF) is vital for B cell survival, proliferation, and maturation. The purpose of this study is to investigate whether BAFF is involved in the B cell survival and eLT formation in NPs. The mRNA and protein levels of BAFF in NP tissues with and without eLTs were detected by PCR and ELISA assay, respectively. The cellular sources of BAFF and active caspase-3-positive B cells in NPs were studied by immunofluorescence staining. B cells purified from NP tissues were stimulated with BAFF and were analyzed by flow cytometry. Stromal cells purified from NP tissues were stimulated with lymphotoxin (LT) α1β2, and BAFF levels in culture supernatants were analyzed by ELISA. Compared with those in control tissues and NPs without eLTs, the BAFF levels were elevated in NPs with eLTs. Abundant BAFF-positive cells and few active caspase-3-positive apoptotic B cells were found in NPs with eLTs, in contrast to those in NPs without eLTs. There was a negative correlation between the numbers of BAFF-positive cells and frequencies of apoptotic B cells in total B cells in NP tissues. BAFF protected nasal polyp B cells from apoptosis in vitro. Stromal cells were an important cellular source of BAFF in NPs with eLTs. LTα1β2 induced BAFF production from nasal stromal cells in vitro. We propose that BAFF contribute to eLT formation in NPs by promoting B cell survival.
Copyright © 2021 Wang, Song, Wang, Li, Xiao, Yu, Liu and Liu.

Entities:  

Keywords:  B cell; B cell-activating factor; ectopic lymphoid tissue; nasal polyp; stromal cell

Year:  2021        PMID: 33552090      PMCID: PMC7854540          DOI: 10.3389/fimmu.2020.625630

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  49 in total

1.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

2.  Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis.

Authors:  Sathish Paramasivan; Susan Lester; Aden Lau; Judy Ou; Alkis James Psaltis; Peter-John Wormald; Sarah Vreugde
Journal:  J Allergy Clin Immunol       Date:  2018-08-07       Impact factor: 10.793

3.  Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.

Authors:  M Murphy; B N Walter; L Pike-Nobile; N A Fanger; P M Guyre; J L Browning; C F Ware; L B Epstein
Journal:  Cell Death Differ       Date:  1998-06       Impact factor: 15.828

Review 4.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes.

Authors:  Ping-Ping Cao; Zhi-Chao Wang; Robert P Schleimer; Zheng Liu
Journal:  Ann Allergy Asthma Immunol       Date:  2018-10-13       Impact factor: 6.347

5.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

Review 6.  BAFF: a fundamental survival factor for B cells.

Authors:  Fabienne Mackay; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

7.  Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.

Authors:  Leen J M Seys; Fien M Verhamme; Anja Schinwald; Hamida Hammad; Danen Mootoosamy Cunoosamy; Claudie Bantsimba-Malanda; Alan Sabirsh; Eileen McCall; Liz Flavell; Ronald Herbst; Sharen Provoost; Bart N Lambrecht; Guy F Joos; Guy G Brusselle; Ken R Bracke
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

8.  Ectopic lymphoid tissues support local immunoglobulin production in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Jia Song; Hai Wang; Ya-Na Zhang; Ping-Ping Cao; Bo Liao; Zhe-Zheng Wang; Li-Li Shi; Yin Yao; Guan-Ting Zhai; Zhi-Chao Wang; Li-Meng Liu; Ming Zeng; Xiang Lu; Heng Wang; Xiang-Ping Yang; Di Yu; Claus Bachert; Zheng Liu
Journal:  J Allergy Clin Immunol       Date:  2017-12-06       Impact factor: 10.793

9.  Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.

Authors:  S D Khare; I Sarosi; X Z Xia; S McCabe; K Miner; I Solovyev; N Hawkins; M Kelley; D Chang; G Van; L Ross; J Delaney; L Wang; D Lacey; W J Boyle; H Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  IFN type I and II induce BAFF secretion from human decidual stromal cells.

Authors:  Anna-Carin Lundell; Inger Nordström; Kerstin Andersson; Christina Lundqvist; Esbjörn Telemo; Silvia Nava; Helen Kaipe; Anna Rudin
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

View more
  3 in total

Review 1.  Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.

Authors:  Amit I Bery; Hailey M Shepherd; Wenjun Li; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Cell Mol Life Sci       Date:  2022-06-11       Impact factor: 9.207

2.  Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Fang Zhang; Zhenhang Xu; Xi He; Yi Sun; Chong Zhao; Jianhui Zhang
Journal:  Mediators Inflamm       Date:  2022-04-08       Impact factor: 4.529

Review 3.  Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence.

Authors:  Alejandro M Palma; Mark R Hanes; Jean S Marshall
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.